1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
2
Active Trials
200 recruiting
5
Rare Diseases
across 9 areas
0
News (30d)
Quiet
Haihe Biopharma Co., Ltd. is a company with 1 orphan drug designation across 5 rare diseases. Active clinical trials in 2 indications.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| lung cancer | glumetinib | Des.TrialAppr. |
| lymphoma | - | Des.TrialAppr. |
| non-small cell lung carcinoma | glumetinib | Des.TrialAppr. |
| non-small cell squamous lung carcinoma | glumetinib | Des.TrialAppr. |
| sarcoma | - | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
41
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
41
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio